Lee, Sang Chul <br/><br/>
Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy.  [electronic resource] 

 -  Cancer research and treatment  Jul 2018 
 - 1023-1038 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2005-9256 
<br/><br/><label>Standard No.: </label>10.4143/crt.2017.085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Autophagy--drug effects<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Proliferation--drug effects<br/>Drug Synergism<br/>Everolimus--administration & dosage<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Mice<br/>Morpholines--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Sirtuin 1--metabolism<br/>Up-Regulation--drug effects<br/>Xenograft Model Antitumor Assays